{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:55:38Z","timestamp":1792299338533,"version":"4.4.0"},"reference-count":61,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:p>\n                    Cardiovascular disease (CVD) is of major concern in women entering menopause. The changing hormonal milieu predisposes them to increased CVD risk, due to a constellation of risk factors, such as visceral obesity, atherogenic dyslipidemia, dysregulation in glucose homeostasis, non-alcoholic fatty liver disease and arterial hypertension. However, an independent association of menopause\n                    <jats:italic>per se<\/jats:italic>\n                    with increased risk of CVD events has only been proven for early menopause (&lt;45 years). Menopausal hormone therapy (MHT) ameliorates most of the CVD risk factors mentioned above. Transdermal estrogens are the preferable regimen, since they do not increase triglyceride concentrations and they are not associated with increased risk of venous thromboembolic events (VTE). Although administration of MHT should be considered on an individual basis, MHT may reduce CVD morbidity and mortality, if commenced during the early postmenopausal period (&lt;60 years or within ten years since the last menstrual period). In women with premature ovarian insufficiency (POI), MHT should be administered at least until the average age of menopause (50\u201352 years). MHT is contraindicated in women with a history of VTE and is not currently recommended for the sole purpose of CVD prevention. The risk of breast cancer associated with MHT is generally low and is mainly conferred by the progestogen. Micronized progesterone and dydrogesterone are associated with lower risk compared to other progestogens.\n                  <\/jats:p>","DOI":"10.1530\/ec-21-0537","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T11:30:20Z","timestamp":1646739020000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":101,"title":["Menopause-associated risk of cardiovascular disease"],"prefix":"10.1530","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8949-4312","authenticated-orcid":true,"given":"Panagiotis","family":"Anagnostis","sequence":"first","affiliation":[{"name":"Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lambrinoudaki","sequence":"additional","affiliation":[{"name":"2nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C","family":"Stevenson","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios G","family":"Goulis","sequence":"additional","affiliation":[{"name":"Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","unstructured":"European Heart Network. European Cardiovascular Disease Statistics 2017 edition. Brussels, Belgium: European Heart Network, 2017. (available at: http:\/\/www.ehnheart.org\/cvd-statistics\/cvd-statistics-2017.html)"},{"key":"bib2","series-title":"European Heart Journal","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehaa1044","article-title":"Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European Cardiologists, Gynaecologists, and Endocrinologists","volume":"42","author":"Maas","year":"2021","unstructured":"Maas AHEMRosano GCifkova RChieffo Avan Dijken DHamoda HKunadian VLaan ELambrinoudaki IMaclaran KCardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European Cardiologists, Gynaecologists, and Endocrinologists. European Heart Journal202142967\u2013984. (https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1044)3349578710.1093\/eurheartj\/ehaa1044"},{"key":"bib3","series-title":"Climacteric","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/13697137.2021.1910232","article-title":"Cardiometabolic health in premature ovarian insufficiency","volume":"24","author":"Stevenson","year":"2021","unstructured":"Stevenson JCCollins PHamoda HLambrinoudaki IMaas AHEMMaclaran KPanay N. Cardiometabolic health in premature ovarian insufficiency. Climacteric202124474\u2013480. (https:\/\/doi.org\/10.1080\/13697137.2021.1910232)3416979510.1080\/13697137.2021.1910232"},{"key":"bib4","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1210\/jc.2011-3362","article-title":"Executive summary of the stages of reproductive aging workshop\u2009+\u200910: addressing the unfinished agenda of staging reproductive aging","volume":"97","author":"Harlow","year":"2012","unstructured":"Harlow SDGass MHall JELobo RMaki PRebar RWSherman SSluss PMde Villiers TJ & STRAW\u2009+\u200910 Collaborative Group. Executive summary of the stages of reproductive aging workshop\u2009+\u200910: addressing the unfinished agenda of staging reproductive aging. Journal of Clinical Endocrinology and Metabolism2012971159\u20131168. (https:\/\/doi.org\/10.1210\/jc.2011-3362)2234419610.1210\/jc.2011-3362"},{"key":"bib5","series-title":"Current Vascular Pharmacology","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2174\/1570161117999190228123237","article-title":"Menopause and its cardiometabolic consequences: current perspectives","volume":"17","author":"Anagnostis","year":"2019","unstructured":"Anagnostis PGoulis DG. Menopause and its cardiometabolic consequences: current perspectives. Current Vascular Pharmacology201917543\u2013545. (https:\/\/doi.org\/10.2174\/1570161117999190228123237)3081607410.2174\/1570161117999190228123237"},{"key":"bib6","series-title":"Current Vascular Pharmacology","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2174\/1570161116666180709095348","article-title":"Menopausal hormone therapy and cardiovascular risk: where are we now?","volume":"17","author":"Anagnostis","year":"2019","unstructured":"Anagnostis PPaschou SAKatsiki NKrikidis DLambrinoudaki IGoulis DG. Menopausal hormone therapy and cardiovascular risk: where are we now?Current Vascular Pharmacology201917564\u2013572. (https:\/\/doi.org\/10.2174\/1570161116666180709095348)2998465910.2174\/1570161116666180709095348"},{"key":"bib7","series-title":"Endocrine Reviews","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1210\/er.2016-1146","article-title":"Menopausal hormone therapy and type 2 diabetes prevention: evidence, mechanisms, and clinical implications","volume":"38","author":"Mauvais-Jarvis","year":"2017","unstructured":"Mauvais-Jarvis FManson JEStevenson JCFonseca VA. Menopausal hormone therapy and type 2 diabetes prevention: evidence, mechanisms, and clinical implications. Endocrine Reviews201738173\u2013188. (https:\/\/doi.org\/10.1210\/er.2016-1146)2832393410.1210\/er.2016-1146"},{"key":"bib8","series-title":"Annals of the New York Academy of Sciences","first-page":"502","article-title":"Menopause-related changes in body fat distribution","volume":"904","author":"Toth","year":"2000","unstructured":"Toth MJTchernof ASites CKPoehlman ET. Menopause-related changes in body fat distribution. Annals of the New York Academy of Sciences2000904502\u2013506. (https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06506.x)10865795"},{"key":"bib9","series-title":"Scientific Reports","doi-asserted-by":"publisher","first-page":"14750","DOI":"10.1038\/s41598-021-94189-2","article-title":"Changes in abdominal subcutaneous adipose tissue phenotype following menopause is associated with increased visceral fat mass","volume":"11","author":"Abildgaard","year":"2021","unstructured":"Abildgaard JPloug TAl-Saoudi EWagner TThomsen CEwertsen CBzorek MPedersen BKPedersen ATLindegaard B. Changes in abdominal subcutaneous adipose tissue phenotype following menopause is associated with increased visceral fat mass. Scientific Reports20211114750. (https:\/\/doi.org\/10.1038\/s41598-021-94189-2)3428530110.1038\/s41598-021-94189-2"},{"key":"bib10","series-title":"American Journal of Obstetrics and Gynecology","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0002-9378(98)70634-9","article-title":"Estrogen regulation of adipose tissue lipoprotein lipase \u2013 possible mechanism of body fat distribution","volume":"178","author":"Price","year":"1998","unstructured":"Price TMO'Brien SNWelter BHGeorge RAnandjiwala JKilgore M. Estrogen regulation of adipose tissue lipoprotein lipase \u2013 possible mechanism of body fat distribution. American Journal of Obstetrics and Gynecology1998178101\u2013107. (https:\/\/doi.org\/10.1016\/s0002-9378(9870634-9)946581110.1016\/S0002-9378(98)70634-9"},{"key":"bib11","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1210\/jc.2001-012034","article-title":"Differences in adipose tissue metabolism between postmenopausal and perimenopausal women","volume":"87","author":"Ferrara","year":"2002","unstructured":"Ferrara CMLynch NANicklas BJRyan ASBerman DM. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. Journal of Clinical Endocrinology and Metabolism2002874166\u20134170. (https:\/\/doi.org\/10.1210\/jc.2001-012034)1221386610.1210\/jc.2001-012034"},{"key":"bib12","series-title":"Cell Metabolism","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cmet.2011.08.009","article-title":"Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction","volume":"14","author":"Xu","year":"2011","unstructured":"Xu YNedungadi TPZhu LSobhani NIrani BGDavis KEZhang XZou FGent LMHahner LDDistinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metabolism201114453\u2013465. (https:\/\/doi.org\/10.1016\/j.cmet.2011.08.009)2198270610.1016\/j.cmet.2011.08.009"},{"key":"bib13","series-title":"European Journal of Clinical Investigation","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2362.1993.tb00792.x","article-title":"The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women","volume":"23","author":"Walton","year":"1993","unstructured":"Walton CGodsland IFProudler AJWynn VStevenson JC. The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. European Journal of Clinical Investigation199323466\u2013473. (https:\/\/doi.org\/10.1111\/j.1365-2362.1993.tb00792.x)840499810.1111\/j.1365-2362.1993.tb00792.x"},{"key":"bib14","series-title":"Diabetes","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2337\/db18-0638","article-title":"Estrogen improves insulin sensitivity and suppresses gluconeogenesis via the transcription factor FoxO1","volume":"68","author":"Yan","year":"2019","unstructured":"Yan HYang WZhou FLi XPan QShen ZHan GNewell-Fugate ATian YMajeti REstrogen improves insulin sensitivity and suppresses gluconeogenesis via the transcription factor FoxO1. Diabetes201968291\u2013304. (https:\/\/doi.org\/10.2337\/db18-0638)3048726510.2337\/db18-0638"},{"key":"bib15","series-title":"Journal of Clinical Epidemiology","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0895-4356(00)00284-5","article-title":"The impact of years since menopause on the development of impaired glucose tolerance","volume":"54","author":"Wu","year":"2001","unstructured":"Wu SIChou PTsai ST. The impact of years since menopause on the development of impaired glucose tolerance. Journal of Clinical Epidemiology200154117\u2013120. (https:\/\/doi.org\/10.1016\/s0895-4356(0000284-5)1116652510.1016\/S0895-4356(00)00284-5"},{"key":"bib16","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1530\/EJE-18-0602","article-title":"Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis","volume":"180","author":"Anagnostis","year":"2019","unstructured":"Anagnostis PChristou KArtzouchaltzi AMGkekas NKKosmidou NSiolos PPaschou SAPotoupnis MKenanidis ETsiridis EEarly menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis. European Journal of Endocrinology201918041\u201350. (https:\/\/doi.org\/10.1530\/EJE-18-0602)3040004710.1530\/EJE-18-0602"},{"key":"bib17","series-title":"Hypertension","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1161\/01.HYP.0000124670.03674.15","article-title":"Novel mechanisms responsible for postmenopausal hypertension","volume":"43","author":"Reckelhoff","year":"2004","unstructured":"Reckelhoff JFFortepiani LA. Novel mechanisms responsible for postmenopausal hypertension. Hypertension200443918\u2013923. (https:\/\/doi.org\/10.1161\/01.HYP.0000124670.03674.15)1502393310.1161\/01.HYP.0000124670.03674.15"},{"key":"bib18","series-title":"Current Opinion in Nephrology and Hypertension","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/MNH.0000000000000404","article-title":"Gender differences in hypertension","volume":"27","author":"Reckelhoff","year":"2018","unstructured":"Reckelhoff JFGender differences in hypertension. Current Opinion in Nephrology and Hypertension201827176\u2013181. (https:\/\/doi.org\/10.1097\/MNH.0000000000000404)2940636410.1097\/MNH.0000000000000404"},{"key":"bib19","series-title":"Journal of Hypertension","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/HJH.0000000000001266","article-title":"Race and sex differences in cardiovascular alpha-adrenergic and beta-adrenergic receptor responsiveness in men and women with high blood pressure","volume":"35","author":"Sherwood","year":"2017","unstructured":"Sherwood AHill LKBlumenthal JAJohnson KSHinderliter AL. Race and sex differences in cardiovascular alpha-adrenergic and beta-adrenergic receptor responsiveness in men and women with high blood pressure. Journal of Hypertension201735975\u2013981. (https:\/\/doi.org\/10.1097\/HJH.0000000000001266)2830663310.1097\/HJH.0000000000001266"},{"key":"bib20","series-title":"Maturitas","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.maturitas.2020.03.006","article-title":"Early menopause is associated with increased risk of arterial hypertension: a systematic review and meta-analysis","volume":"135","author":"Anagnostis","year":"2020","unstructured":"Anagnostis PTheocharis PLallas KKonstantis GMastrogiannis KBosdou JKLambrinoudaki IStevenson JCGoulis DG. Early menopause is associated with increased risk of arterial hypertension: a systematic review and meta-analysis. Maturitas202013574\u201379. (https:\/\/doi.org\/10.1016\/j.maturitas.2020.03.006)3225296810.1016\/j.maturitas.2020.03.006"},{"key":"bib21","series-title":"Diabetes, Obesity and Metabolism","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","article-title":"Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women","volume":"8","author":"Salpeter","year":"2006","unstructured":"Salpeter SRWalsh JMOrmiston TMGreyber EBuckley NSSalpeter EE. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes, Obesity and Metabolism20068538\u2013554. (https:\/\/doi.org\/10.1111\/j.1463-1326.2005.00545.x)1691858910.1111\/j.1463-1326.2005.00545.x"},{"key":"bib22","series-title":"Maturitas","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.maturitas.2015.02.262","article-title":"Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions","volume":"81","author":"Anagnostis","year":"2015","unstructured":"Anagnostis PStevenson JCCrook DJohnston DGGodsland IF. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions. Maturitas20158162\u201368. (https:\/\/doi.org\/10.1016\/j.maturitas.2015.02.262)2580495110.1016\/j.maturitas.2015.02.262"},{"key":"bib23","series-title":"Clinical Endocrinology","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/cen.13085","article-title":"Effects of gender, age and menopausal status on serum apolipoprotein concentrations","volume":"85","author":"Anagnostis","year":"2016","unstructured":"Anagnostis PStevenson JCCrook DJohnston DGGodsland IF. Effects of gender, age and menopausal status on serum apolipoprotein concentrations. Clinical Endocrinology201685733\u2013740. (https:\/\/doi.org\/10.1111\/cen.13085)2708656510.1111\/cen.13085"},{"key":"bib24","series-title":"Journal of the American College of Cardiology","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","unstructured":"Tsimikas STest A. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies. Journal of the American College of Cardiology201769692\u2013711. (https:\/\/doi.org\/10.1016\/j.jacc.2016.11.042)2818351210.1016\/j.jacc.2016.11.042"},{"key":"bib25","series-title":"International Journal of Clinical Practice","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/ijcp.12903","article-title":"Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options","volume":"70","author":"Anagnostis","year":"2016","unstructured":"Anagnostis PKarras SLambrinoudaki IStevenson JCGoulis DG. Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options. International Journal of Clinical Practice201670967\u2013977. (https:\/\/doi.org\/10.1111\/ijcp.12903)2803242610.1111\/ijcp.12903"},{"key":"bib26","series-title":"Maturitas","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.maturitas.2021.06.012","article-title":"The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause","volume":"151","author":"Robeva","year":"2021","unstructured":"Robeva RMladenovic DVeskovic MHrncic DBjekic-Macut JStanojlovic OLivadas SYildiz BOMacut D. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause. Maturitas202115122\u201330. (https:\/\/doi.org\/10.1016\/j.maturitas.2021.06.012)3444627510.1016\/j.maturitas.2021.06.012"},{"key":"bib27","series-title":"Current Vascular Pharmacology","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2174\/1570161116666180711121949","article-title":"Menopause and non-alcoholic fatty liver disease: a review focusing on therapeutic perspectives","volume":"17","author":"Venetsanaki","year":"2019","unstructured":"Venetsanaki VPolyzos SA. Menopause and non-alcoholic fatty liver disease: a review focusing on therapeutic perspectives. Current Vascular Pharmacology201917546\u2013555. (https:\/\/doi.org\/10.2174\/1570161116666180711121949)2999288610.2174\/1570161116666180711121949"},{"key":"bib28","series-title":"Menopause","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/GME.0000000000000352","article-title":"Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index","volume":"22","author":"Wang","year":"2015","unstructured":"Wang ZXu MHu ZShrestha UK. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. Menopause201522667\u2013673. (https:\/\/doi.org\/10.1097\/GME.0000000000000352)2551398310.1097\/GME.0000000000000352"},{"key":"bib29","series-title":"Annals of Internal Medicine","doi-asserted-by":"publisher","first-page":"447","DOI":"10.7326\/0003-4819-85-4-447","article-title":"Menopause and risk of cardiovascular disease: the Framingham study","volume":"85","author":"Kannel","year":"1976","unstructured":"Kannel WBHjortland MCMcNamara PMGordon T. Menopause and risk of cardiovascular disease: the Framingham study. Annals of Internal Medicine197685447\u2013452. (https:\/\/doi.org\/10.7326\/0003-4819-85-4-447)97077010.7326\/0003-4819-85-4-447"},{"key":"bib30","series-title":"Annals of Internal Medicine","doi-asserted-by":"publisher","first-page":"157","DOI":"10.7326\/0003-4819-89-2-157","article-title":"Menopause and coronary heart disease. The Framingham Study","volume":"89","author":"Gordon","year":"1978","unstructured":"Gordon TKannel WBHjortland MCMcNamara PM. Menopause and coronary heart disease. The Framingham Study. Annals of Internal Medicine197889157\u2013161. (https:\/\/doi.org\/10.7326\/0003-4819-89-2-157)67757610.7326\/0003-4819-89-2-157"},{"key":"bib31","series-title":"New England Journal of Medicine","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/NEJM198704303161801","article-title":"Menopause and the risk of coronary heart disease in women","volume":"316","author":"Colditz","year":"1987","unstructured":"Colditz GAWillett WCStampfer MJRosner BSpeizer FEHennekens CH. Menopause and the risk of coronary heart disease in women. New England Journal of Medicine19873161105\u20131110. (https:\/\/doi.org\/10.1056\/NEJM198704303161801)357435810.1056\/NEJM198704303161801"},{"key":"bib32","series-title":"JAMA Cardiology","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/jamacardio.2016.2415","article-title":"Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis","volume":"1","author":"Muka","year":"2016","unstructured":"Muka TOliver-Williams CKunutsor SLaven JSFauser BCChowdhury RKavousi MFranco OH. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis. JAMA Cardiology20161767\u2013776. (https:\/\/doi.org\/10.1001\/jamacardio.2016.2415)2762719010.1001\/jamacardio.2016.2415"},{"key":"bib33","series-title":"Climacteric","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/13697137.2015.1094784","article-title":"Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis","volume":"19","author":"Tao","year":"2016","unstructured":"Tao XYZuo AZWang JQTao FB. Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis. Climacteric20161927\u201336. (https:\/\/doi.org\/10.3109\/13697137.2015.1094784)2657601210.3109\/13697137.2015.1094784"},{"key":"bib34","series-title":"European Journal of Preventive Cardiology","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/2047487314556004","article-title":"Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis","volume":"23","author":"Roeters van Lennep","year":"2016","unstructured":"Roeters van Lennep JEHeida KYBots MLHoek A & collaborators of the Dutch Multidisciplinary Guideline Development Group on Cardiovascular Risk Management after Reproductive Disorders. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. European Journal of Preventive Cardiology201623178\u2013186. (https:\/\/doi.org\/10.1177\/2047487314556004)2533120710.1177\/2047487314556004"},{"key":"bib35","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1001\/jama.2019.19191","article-title":"Association of premature natural and surgical menopause with incident cardiovascular disease","volume":"322","author":"Honigberg","year":"2019","unstructured":"Honigberg MCZekavat SMAragam KFinneran PKlarin DBhatt DLJanuzzi JLJrScott NSNatarajan P. Association of premature natural and surgical menopause with incident cardiovascular disease. JAMA20193222411\u20132421. (https:\/\/doi.org\/10.1001\/jama.2019.19191)3173881810.1001\/jama.2019.19191"},{"key":"bib36","series-title":"Maturitas","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.maturitas.2017.02.009","article-title":"The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: a systematic review and meta-analysis","volume":"99","author":"Anagnostis","year":"2017","unstructured":"Anagnostis PGalanis PChatzistergiou VStevenson JCGodsland IFLambrinoudaki ITheodorou MGoulis DG. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: a systematic review and meta-analysis. Maturitas20179927\u201336. (https:\/\/doi.org\/10.1016\/j.maturitas.2017.02.009)2836486510.1016\/j.maturitas.2017.02.009"},{"key":"bib37","series-title":"Obstetrics and Gynecology","first-page":"887","article-title":"ACOG committee opinion no. 556: postmenopausal estrogen therapy: route of administration and risk of venous thromboembolism","volume":"121","year":"2013","unstructured":"ACOG committee opinion no. 556: postmenopausal estrogen therapy: route of administration and risk of venous thromboembolism. Obstetrics and Gynecology2013121887\u2013890. (https:\/\/doi.org\/10.1097\/01.AOG.0000428645.90795.d9)23635705"},{"key":"bib38","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1210\/jc.2015-2236","article-title":"Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline","volume":"100","author":"Stuenkel","year":"2015","unstructured":"Stuenkel CADavis SRGompel ALumsden MAMurad MHPinkerton JVSanten RJ. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism20151003975\u20134011. (https:\/\/doi.org\/10.1210\/jc.2015-2236)2644499410.1210\/jc.2015-2236"},{"key":"bib39","series-title":"Maturitas","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.maturitas.2020.03.007","article-title":"Menopause symptom management in women with dyslipidemias: an EMAS clinical guide","volume":"135","author":"Anagnostis","year":"2020","unstructured":"Anagnostis PBitzer JCano ACeausu IChedraui PDurmusoglu FErkkola RGoulis DGHirschberg ALKiesel LMenopause symptom management in women with dyslipidemias: an EMAS clinical guide. Maturitas202013582\u201388. (https:\/\/doi.org\/10.1016\/j.maturitas.2020.03.007)3220927910.1016\/j.maturitas.2020.03.007"},{"key":"bib40","series-title":"Annals of Internal Medicine","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.7326\/0003-4819-117-12-1016","article-title":"Hormone therapy to prevent disease and prolong life in postmenopausal women","volume":"117","author":"Grady","year":"1992","unstructured":"Grady DRubin SMPetitti DBFox CSBlack DEttinger BErnster VLCummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Annals of Internal Medicine19921171016\u20131037. (https:\/\/doi.org\/10.7326\/0003-4819-117-12-1016)144397110.7326\/0003-4819-117-12-1016"},{"key":"bib41","series-title":"Preventive Medicine","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0091-7435(91)90006-P","article-title":"Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence","volume":"20","author":"Stampfer","year":"1991","unstructured":"Stampfer MJColditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Preventive Medicine19912047\u201363. (https:\/\/doi.org\/10.1016\/0091-7435(9190006-p)182617310.1016\/0091-7435(91)90006-P"},{"key":"bib42","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","unstructured":"Rossouw JEAnderson GLPrentice RLLaCroix AZKooperberg CStefanick MLJackson RDBeresford SAHoward BVJohnson KCRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA2002288321\u2013333. (https:\/\/doi.org\/10.1001\/jama.288.3.321)1211739710.1001\/jama.288.3.321"},{"key":"bib43","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women\u2019s Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","unstructured":"Manson JEChlebowski RTStefanick MLAragaki AKRossouw JEPrentice RLAnderson GHoward BVThomson CALaCroix AZMenopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women\u2019s Health Initiative randomized trials. JAMA20133101353\u20131368. (https:\/\/doi.org\/10.1001\/jama.2013.278040)2408492110.1001\/jama.2013.278040"},{"key":"bib44","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","unstructured":"Anderson GLLimacher MAssaf ARBassford TBeresford SABlack HBonds DBrunner RBrzyski RCaan BEffects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial. JAMA20042911701\u20131712. (https:\/\/doi.org\/10.1001\/jama.291.14.1701)1508269710.1001\/jama.291.14.1701"},{"key":"bib45","series-title":"European Heart Journal","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1093\/eurheartj\/ehn408","article-title":"Hormone therapy and risk of myocardial infarction: a national register study","volume":"29","author":"Lokkegaard","year":"2008","unstructured":"Lokkegaard EAndreasen AHJacobsen RKNielsen LHAgger CLidegaard \u00d8. Hormone therapy and risk of myocardial infarction: a national register study. European Heart Journal2008292660\u20132668. (https:\/\/doi.org\/10.1093\/eurheartj\/ehn408)1882698910.1093\/eurheartj\/ehn408"},{"key":"bib46","series-title":"Cochrane Database of Systematic Reviews","article-title":"Hormone therapy for preventing cardiovascular disease in post-menopausal women","volume":"10","author":"Boardman","year":"2015","unstructured":"Boardman HMHartley LEisinga AMain CRoqu\u00e9 i Figuls MBonfill Cosp XGabriel Sanchez RKnight B. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database of Systematic Reviews201510 CD002229. (https:\/\/doi.org\/10.1002\/14651858.CD002229.pub4)"},{"key":"bib47","series-title":"New England Journal of Medicine","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","unstructured":"Hodis HNMack WJHenderson VWShoupe DBudoff MJHwang-Levine JLi YFeng MDustin LKono NVascular effects of early versus late postmenopausal treatment with estradiol. New England Journal of Medicine20163741221\u20131231. (https:\/\/doi.org\/10.1056\/NEJMoa1505241)2702891210.1056\/NEJMoa1505241"},{"key":"bib48","series-title":"BMJ","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial","volume":"345","author":"Schierbeck","year":"2012","unstructured":"Schierbeck LLRejnmark LTofteng CLStilgren LEiken PMosekilde LKober LJensen JE. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ2012345 e6409. (https:\/\/doi.org\/10.1136\/bmj.e6409)23048011"},{"key":"bib49","series-title":"Annals of Internal Medicine","doi-asserted-by":"publisher","first-page":"249","DOI":"10.7326\/M14-0353","article-title":"Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial","volume":"161","author":"Harman","year":"2014","unstructured":"Harman SMBlack DMNaftolin FBrinton EABudoff MJCedars MIHopkins PNLobo RAManson JEMerriam GRArterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Annals of Internal Medicine2014161249\u2013260. (https:\/\/doi.org\/10.7326\/M14-0353)2506999110.7326\/M14-0353"},{"key":"bib50","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/Progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","unstructured":"Hulley SGrady DBush TFurberg CHerrington DRiggs BVittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/Progestin Replacement Study (HERS) Research Group. JAMA1998280605\u2013613. (https:\/\/doi.org\/10.1001\/jama.280.7.605)10.1001\/jama.280.7.605"},{"key":"bib51","series-title":"Menopause International","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1754045313489645","article-title":"The 2013 British Menopause Society & Women\u2019s Health Concern recommendations on hormone replacement therapy","volume":"19","author":"Panay","year":"2013","unstructured":"Panay NHamoda HArya RSavvas M & British Menopause Society andWomen\u2019sHealth Concern. The 2013 British Menopause Society & Women\u2019s Health Concern recommendations on hormone replacement therapy. Menopause International20131959\u201368. (https:\/\/doi.org\/10.1177\/1754045313489645)2376131910.1177\/1754045313489645"},{"key":"bib52","series-title":"Maturitas","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.maturitas.2010.10.005","article-title":"EMAS position statement: managing the menopause in the context of coronary heart disease","volume":"68","author":"Schenck-Gustafsson","year":"2011","unstructured":"Schenck-Gustafsson KBrincat MErel CTGambacciani MLambrinoudaki IMoen MHTremollieres FVujovic SRozenberg SRees MEMAS position statement: managing the menopause in the context of coronary heart disease. Maturitas20116894\u201397. (https:\/\/doi.org\/10.1016\/j.maturitas.2010.10.005)2115634110.1016\/j.maturitas.2010.10.005"},{"key":"bib53","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1210\/jc.2015-1864","article-title":"Increased cardiovascular mortality risk in women discontinuing postmenopausal hormone therapy","volume":"100","author":"Mikkola","year":"2015","unstructured":"Mikkola TSTuomikoski PLyytinen HKorhonen PHoti FVattulainen PGissler MYlikorkala O. Increased cardiovascular mortality risk in women discontinuing postmenopausal hormone therapy. Journal of Clinical Endocrinology and Metabolism20151004588\u20134594. (https:\/\/doi.org\/10.1210\/jc.2015-1864)2641496210.1210\/jc.2015-1864"},{"key":"bib54","series-title":"Systematic Reviews","article-title":"Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis","volume":"5","author":"Asi","year":"2016","unstructured":"Asi NMohammed KHaydour QGionfriddo MRVargas OLProkop LJFaubion SSMurad MH. Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis. Systematic Reviews20165 121. (https:\/\/doi.org\/10.1186\/s13643-016-0294-5)27456847"},{"key":"bib55","series-title":"Climacteric","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/13697137.2017.1421925","article-title":"The impact of micronized progesterone on breast cancer risk: a systematic review","volume":"21","author":"Stute","year":"2018","unstructured":"Stute PWildt LNeulen J. The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric201821111\u2013122. (https:\/\/doi.org\/10.1080\/13697137.2017.1421925)2938440610.1080\/13697137.2017.1421925"},{"key":"bib56","series-title":"Maturitas","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.maturitas.2018.08.009","article-title":"Menopause and diabetes: EMAS clinical guide","volume":"117","author":"Slopien","year":"2018","unstructured":"Slopien RWender-Ozegowska ERogowicz-Frontczak AMeczekalski BZozulinska-Ziolkiewicz DJaremek JDCano AChedraui PGoulis DGLopes PMenopause and diabetes: EMAS clinical guide. Maturitas20181176\u201310. (https:\/\/doi.org\/10.1016\/j.maturitas.2018.08.009)3031456310.1016\/j.maturitas.2018.08.009"},{"key":"bib57","series-title":"European Heart Journal","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","unstructured":"Mach FBaigent CCatapano ALKoskinas KCCasula MBadimon LChapman MJDe Backer GGDelgado VFerence BA2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal202041111\u2013188. (https:\/\/doi.org\/10.1093\/eurheartj\/ehz455)3150441810.1093\/eurheartj\/ehz455"},{"key":"bib58","series-title":"European Heart Journal","first-page":"2439","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","year":"2021","unstructured":"SCORE2 Working Group and ESC Cardiovascular Risk Collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. European Heart Journal2021422439\u20132454. (https:\/\/doi.org\/10.1093\/eurheartj\/ehab309)34120177"},{"key":"bib59","series-title":"European Heart Journal","first-page":"2455","article-title":"SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions","volume":"42","year":"2021","unstructured":"SCORE2-OPWorking Group and ESC CardiovascularRisk Collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. European Heart Journal2021422455\u20132467. (https:\/\/doi.org\/10.1093\/eurheartj\/ehab312)34120185"},{"key":"bib60","series-title":"European Heart Journal","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","unstructured":"Visseren FLJMach FSmulders YMCarballo DKoskinas KCBack MBenetos ABiffi ABoavida JMCapodanno D2021 ESC guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal2021423227\u20133337. (https:\/\/doi.org\/10.1093\/eurheartj\/ehab484)3445890510.1093\/eurheartj\/ehab484"},{"key":"bib61","series-title":"Circulation","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","unstructured":"Grundy SMStone NJBailey ALBeam CBirtcher KKBlumenthal RSBraun LTde Ferranti SFaiella-Tommasino JForman DE2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Circulation2019139e1082\u2013e1143. (https:\/\/doi.org\/10.1161\/CIR.0000000000000625)"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/11\/4\/EC-21-0537.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/11\/4\/EC-21-0537.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/11\/4\/EC-21-0537.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:45:05Z","timestamp":1784555105000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":61,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1530\/ec-21-0537","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}